Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems

Addiction Science & Clinical Practice

Jeffrey H. Samet¹  Sarah M. Bagley¹  Jordan M. Braciszewski²  Andrew J. Saxon³  Ingrid A. Binswanger⁴  Cynthia I. Campbell⁵  Rebecca C. Rossom⁶  Bobbi Jo H. Yarborough⁷  Mary Akolsile⁸  Joseph E. Glass⁸  Denise M. Boudreau⁸  Katharine A. Bradley⁸  Mark T. Murphy⁹  Gwen Lapham^1,10  Laura Chavez^1,10  Gavin Bart^1,11 

[1] Boston Medical Center, Boston University, Boston, USA;Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, USA;Department of Psychiatry, Henry Ford Health System, Detroit, USA;Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System/University of Washington School of Medicine, Seattle, USA;Colorado Permanente Medical Group, Kaiser Permanente Colorado, The University of Colorado School of Medicine and The Kaiser Permanente Bernard J. Tyson School of Medicine, Aurora, USA;Division of Research, Kaiser Permanente Northern California, Oakland, USA;Health Partners Institute/University of Minnesota, Minneapolis, USA;Kaiser Permanente Northwest Center for Health Research, Portland, USA;Kaiser Permanente Washington Health Research Institute, Seattle, USA;MultiCare Institute for Research and Innovation, MultiCare Health System WA, Tacoma, USA;Nationwide Children’s Hospital, Abigail Wexner Research Institute, Columbus, USA;University of Minnesota Medical School/Hennepin Healthcare, Minneapolis, USA;

关键词: Opioid use disorder;    Adolescents;    Young adults;    Medication for opioid use disorder;    Buprenorphine;    Naltrexone;   

DOI  :  10.1186/s13722-021-00249-3

来源: Springer

【 摘 要 】

PurposeLittle is known about prevalence and treatment of OUD among youth engaged in primary care (PC). Medications are the recommended treatment of opioid use disorder (OUD) for adolescents and young adults (youth). This study describes the prevalence of OUD, the prevalence of medication treatment for OUD, and patient characteristics associated with OUD treatment among youth engaged in PC.MethodsThis cross-sectional study includes youth aged 16–25 years engaged in PC. Eligible patients had ≥ 1 PC visit during fiscal years (FY) 2014–2016 in one of 6 health systems across 6 states. Data from electronic health records and insurance claims were used to identify OUD diagnoses, office-based OUD medication treatment, and patient demographic and clinical characteristics in the FY of the first PC visit during the study period. Descriptive analyses were conducted in all youth, and stratified by age (16–17, 18–21, 22–25 years).ResultsAmong 303,262 eligible youth, 2131 (0.7%) had a documented OUD diagnosis. The prevalence of OUD increased by ascending age groups. About half of youth with OUD had documented depression or anxiety and one third had co-occurring substance use disorders. Receipt of medication for OUD was lowest among youth 16–17 years old (14%) and highest among those aged 22–25 (39%).ConclusionsIn this study of youth engaged in 6 health systems across 6 states, there was low receipt of medication treatment, and high prevalence of other substance use disorders and mental health disorders. These findings indicate an urgent need to increase medication treatment for OUD and to integrate treatment for other substance use and mental health disorders.

【 授权许可】

CC BY